Cyclica

18 King Street East
Suite 810
Toronto
Ontario
M5C 1C4
Canada

Tel: 416-304-9201

Email: inquiries@cyclicarx.com

Show jobs for this employer

About Cyclica

Cyclica Inc. has developed, validated, patented and commercialized Ligand Express™, a cloud-based Software-as-a-Service platform that screens small-molecule drugs against repositories of structurally-characterized proteins or ‘proteomes’ to determine polypharmacological profiles. Accordingly, Ligand Express™ identifies significant protein targets using an innovative structure-based and drug-centric technology, leverages artificial intelligence to determine the drug’s effect on these targets, and visualizes the predicted drug-protein interactome using bioinformatics and systems biology. The platform provides a unique panoramic view of a small-molecule, by identifying on- and off-target interactions that may be expected, as well as those that are unanticipated. By understanding how a small-molecule drug will interact with all proteins in the body, Ligand Express™ augments scientific investigation by elucidating mechanism of action, prioritizing lead candidates, understanding side effects, as well as determining new uses for existing drugs.

YEAR FOUNDED:

April 30, 2010

JOBS:

Please click here for Cyclica job opportunities.

21 articles with Cyclica